XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.3
SEGMENT INFORMATION
 9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
Effective July 1, 2024, Image Guided Therapies, previously part of the Imaging segment, was realigned to the Ultrasound segment to better match its clinical usage and realize stronger business and customer impact by providing the right image guidance in the right care setting. The Ultrasound segment was subsequently renamed Advanced Visualization Solutions. The AVS segment has a portfolio that serves customers across two core areas: Specialized Ultrasound and Procedural Guidance. Specialized Ultrasound includes Radiology, Primary Care and Point of Care, and Women’s Health Ultrasound. Procedural Guidance includes Cardiovascular and Interventional Solutions, and Surgical Innovations. Under the new structure, IGT is reported within the Procedural Guidance business in AVS. Historical segment financial information presented within this report has been recast to conform to the new reportable segments structure.

Following this realignment, the Company continues to have four reportable segments: Imaging, AVS, PCS, and PDx. These segments have been identified based on the nature of the products sold and how the Company manages its operations. We have not aggregated any of our operating segments to form reportable segments.

The performance of these segments was principally measured based on Total revenues and an earnings metric defined as “Segment EBIT.” Segment EBIT is calculated as income before income taxes in our Condensed Consolidated Statements of Income excluding the impact of the following: Interest and other financial charges – net, Non-operating benefit (income) costs, restructuring costs, acquisition and disposition-related benefits (charges), gain (loss) on business and asset dispositions, Spin-Off and separation costs, amortization of acquisition-related intangible assets, and investment revaluation gain (loss).

Total Revenues by Segment
For the three months ended September 30
For the nine months ended September 30
2024202320242023
Total Imaging$2,229 $2,236 $6,462 $6,552 
AVS:
Procedural Guidance647 641 1,967 1,938 
Specialized Ultrasound569 573 1,725 1,774 
Total AVS
1,216 1,214 3,692 3,712 
PCS:
Monitoring Solutions
556 573 1,621 1,688 
Life Support Solutions
223 191 677 627 
Total PCS779 764 2,298 2,315 
Total PDx625 589 1,862 1,715 
Other(1)
15 19 39 52 
Total revenues$4,863 $4,822 $14,353 $14,346 
(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services (“HFS”) which does not meet the definition of an operating segment.
Segment EBIT
For the three months ended September 30
For the nine months ended September 30
2024202320242023
Segment EBIT
Imaging$287 $243 $660 $566 
AVS
232 254 744 798 
PCS 82 80 241 273 
PDx 193 166 571 473 
Other(1)
1 1 2 9 
795 744 2,217 2,119 
Restructuring costs(22)(3)(90)(34)
Acquisition and disposition-related benefits (charges)
4 14 7 15 
Gain (loss) on business and asset dispositions
(1)— — — 
Spin-Off and separation costs(56)(45)(182)(175)
Amortization of acquisition-related intangible assets(34)(32)(100)(95)
Investment revaluation gain (loss)(1)2 (26)1 
Interest and other financial charges – net(130)(138)(383)(411)
Non-operating benefit income (costs)102 94 306 332 
Income before income taxes
$658 $636 $1,747 $1,752 
(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.